Viz.ai Claimed Company
Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 200 million lives across 1,200+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by clinical data, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. The company was named to the Forbes 2021 Next Billion-Dollar Startups list of the 25 fastest-growing venture-backed startups and has been on the Forbes AI 50 list for three consecutive years. For more information visit viz.ai. read more
Steve Sweeny — Vice President, Strategy and Business Development at Viz.ai
Executive Bio
Steve currently leads Strategy and Business Development at Viz.ai.
Steve has over ten years of leadership experience within the healthcare industry. Prior to Viz, Steve spent seven years at Medtronic, where he had various roles in Business Development, Strategy, and M&A. Throughout his time at Medtronic, Steve had closed 25 transactions across multiple disease states and device categories, with transactions running the gamut from traditional buy-side to sell-side to venture investment to strategic partnerships. Most recently, Steve led Business Development, Strategy, and Portfolio Management for Medtronic’s Neuroscience Division.
Prior to Medtronic, Steve received his MBA from Wharton, focusing on Healthcare Management. Prior to graduate school, Steve spent five years in management consulting, serving the Pharmaceutical and Biotechnology industries.
Steve is originally from Delaware and is a proud Georgetown alum.
Steve has over ten years of leadership experience within the healthcare industry. Prior to Viz, Steve spent seven years at Medtronic, where he had various roles in Business Development, Strategy, and M&A. Throughout his time at Medtronic, Steve had closed 25 transactions across multiple disease states and device categories, with transactions running the gamut from traditional buy-side to sell-side to venture investment to strategic partnerships. Most recently, Steve led Business Development, Strategy, and Portfolio Management for Medtronic’s Neuroscience Division.
Prior to Medtronic, Steve received his MBA from Wharton, focusing on Healthcare Management. Prior to graduate school, Steve spent five years in management consulting, serving the Pharmaceutical and Biotechnology industries.
Steve is originally from Delaware and is a proud Georgetown alum.
Executive Team Culture Ratings from Viz.ai Employees
TOP
5%
Viz.ai's Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Viz.ai's Executive Team at a Glance
Based on 196 ratings, Viz.ai's employees are very satisfied with their Executive Team and give them an “A+” or 87/100. On average, Women provided higher ratings for their Executive Team compared to Men. Also, the IT department thinks more highly of the Executive Team relative to the Finance department.
Viz.ai's Executive Team ranks in the Top 5% of other companies in San Francisco and Top 5% of other companies on Comparably that also have 201-500 Employees.
×